181 related articles for article (PubMed ID: 28447863)
1. Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.
Banks DB; Chan GN; Evans RA; Miller DS; Cannon RE
J Cereb Blood Flow Metab; 2018 May; 38(5):857-868. PubMed ID: 28447863
[TBL] [Abstract][Full Text] [Related]
2. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls.
Uhr M; Grauer MT; Yassouridis A; Ebinger M
J Psychiatr Res; 2007; 41(1-2):179-88. PubMed ID: 16387324
[TBL] [Abstract][Full Text] [Related]
4. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid receptor, LPA
Masago K; Kihara Y; Yanagida K; Hamano F; Nakagawa S; Niwa M; Shimizu T
Biochem Biophys Res Commun; 2018 Jul; 501(4):1048-1054. PubMed ID: 29778535
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone changes the pharmacokinetics of amitriptyline and reduces its accumulation in rat brain: The roles of P-gp and cyp3a2.
Wen J; Shen Y; Zhang M; Wang C; Xiang Y; Cai H; Fang P; Li H
J Pharmacol Sci; 2019 May; 140(1):54-61. PubMed ID: 31105024
[TBL] [Abstract][Full Text] [Related]
7. Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling.
Mesev EV; Miller DS; Cannon RE
Mol Pharmacol; 2017 Apr; 91(4):373-382. PubMed ID: 28119480
[TBL] [Abstract][Full Text] [Related]
8. Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.
Hawkins BT; Sykes DB; Miller DS
J Neurosci; 2010 Jan; 30(4):1417-25. PubMed ID: 20107068
[TBL] [Abstract][Full Text] [Related]
9. [Effect of lysophosphatidic acid increase the permeability of blood-brain barrier model].
Gan N; Yin F; Peng J; Wang WD
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):416-8. PubMed ID: 18581898
[TBL] [Abstract][Full Text] [Related]
10. Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.
Mohamed LA; Markandaiah S; Bonanno S; Pasinelli P; Trotti D
AAPS J; 2017 Nov; 19(6):1600-1614. PubMed ID: 28779378
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.
McCaffrey G; Staatz WD; Sanchez-Covarrubias L; Finch JD; Demarco K; Laracuente ML; Ronaldson PT; Davis TP
J Neurochem; 2012 Sep; 122(5):962-75. PubMed ID: 22716933
[TBL] [Abstract][Full Text] [Related]
12. Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS.
Wang X; Hawkins BT; Miller DS
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1371-5. PubMed ID: 21487415
[TBL] [Abstract][Full Text] [Related]
13. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.
Miller DS; Bauer B; Hartz AM
Pharmacol Rev; 2008 Jun; 60(2):196-209. PubMed ID: 18560012
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
Qosa H; Lichter J; Sarlo M; Markandaiah SS; McAvoy K; Richard JP; Jablonski MR; Maragakis NJ; Pasinelli P; Trotti D
Glia; 2016 Aug; 64(8):1298-313. PubMed ID: 27158936
[TBL] [Abstract][Full Text] [Related]
15. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier.
Hartz AM; Bauer B; Block ML; Hong JS; Miller DS
FASEB J; 2008 Aug; 22(8):2723-33. PubMed ID: 18474546
[TBL] [Abstract][Full Text] [Related]
16. Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.
On NH; Savant S; Toews M; Miller DW
J Cereb Blood Flow Metab; 2013 Dec; 33(12):1944-54. PubMed ID: 24045401
[TBL] [Abstract][Full Text] [Related]
17. Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.
Rigor RR; Hawkins BT; Miller DS
J Cereb Blood Flow Metab; 2010 Jul; 30(7):1373-83. PubMed ID: 20197783
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cerebromicrovascular permeability by lysophosphatidic acid.
Sarker MH; Hu DE; Fraser PA
Microcirculation; 2010 Jan; 17(1):39-46. PubMed ID: 20141599
[TBL] [Abstract][Full Text] [Related]
19. Modulation of p-glycoprotein transport function at the blood-brain barrier.
Bauer B; Hartz AM; Fricker G; Miller DS
Exp Biol Med (Maywood); 2005 Feb; 230(2):118-27. PubMed ID: 15673560
[TBL] [Abstract][Full Text] [Related]
20. Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking.
Tome ME; Jarvis CK; Schaefer CP; Jacobs LM; Herndon JM; Hunn KC; Arkwright NB; Kellohen KL; Mierau PC; Davis TP
J Cereb Blood Flow Metab; 2018 Dec; 38(12):2209-2222. PubMed ID: 30346224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
